The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America
Open accessPublished version of a preprint
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
The evolution of SARS-CoV-2 variants with potentially increased transmissibility, virulence, and resistance to antibody neutralization poses new challenges for the control of COVID-19 (1), particularly in low- and middle-income countries (LMICs) where transmission remains high and vaccination progress is still incipient...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Lambda (GR/452Q.V1) variant originated in Peru in August 2020 [49]. Previously known as C.37 or Andean variant, this could be a new emerging threat; therefore, WHO on June 14, 2021 declared this as a VOI [50].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [49]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The Lambda (GR/452Q.V1) variant originated in Peru in August 2020 [49].”
From Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe (2022) · cites this paper as [49]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Weisblum, Y., Schmidt, F., Zhang, F., DaSilva, J., Poston, D., Lorenzi, J. C., Muecksch, F., Rutkowska, M., Hoffmann, H.-H., Michailidis, E., et al. (2020) · eLife · doi:10.7554/elife.61312 · Cited by 1,308
Liu, Z., VanBlargan, L. A., Bloyet, L.-M., Rothlauf, P. W., Chen, R. E., Stumpf, S., Zhao, H., Errico, J. M., Theel, E. S., Liebeskind, M. J., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.01.014 · Cited by 725
Mutations Strengthened SARS-CoV-2 Infectivity
Chen, J., Wang, R., Wang, M., & Wei, G.-W. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.07.009 · Cited by 466
Augur: a bioinformatics toolkit for phylogenetic analyses of human pathogens
Huddleston, J., Hadfield, J., Sibley, T., Lee, J., Fay, K., Ilcisin, M., Harkins, E., Bedford, T., Neher, R., & Hodcroft, E. (2021) · Journal of Open Source Software · doi:10.21105/joss.02906 · Cited by 234
Multiplex qPCR discriminates variants of concern to enhance global surveillance of SARS-CoV-2
Vogels, C. B. F., Breban, M. I., Ott, I. M., Alpert, T., Petrone, M. E., Watkins, A. E., Kalinich, C. C., Earnest, R., Rothman, J. E., Goes de Jesus, J., et al. (2021) · PLOS Biology · doi:10.1371/journal.pbio.3001236 · Cited by 226
Public health actions to control new SARS-CoV-2 variants
Grubaugh, N. D., Hodcroft, E. B., Fauver, J. R., Phelan, A. L., & Cevik, M. (2021) · Cell · doi:10.1016/j.cell.2021.01.044 · Cited by 147
Cited by
The next phase of SARS-CoV-2 surveillance: real-time molecular epidemiology
Oude Munnink, B. B., Worp, N., Nieuwenhuijse, D. F., Sikkema, R. S., Haagmans, B., Fouchier, R. A. M., & Koopmans, M. (2021) · Nature Medicine · doi:10.1038/s41591-021-01472-w · Cited by 231
The role of NSP6 in the biogenesis of the SARS-CoV-2 replication organelle
Ricciardi, S., Guarino, A. M., Giaquinto, L., Polishchuk, E. V., Santoro, M., Di Tullio, G., Wilson, C., Panariello, F., Soares, V. C., Dias, S. S. G., et al. (2022) · Nature · doi:10.1038/s41586-022-04835-6 · Cited by 214
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, V., Bhola, S., Thakur, P., Patel, S. K. S., Kulshrestha, S., Ratho, R. K., & Kumar, P. (2022) · Infection · doi:10.1007/s15010-021-01734-2 · Cited by 195
Evolutionary trajectory of SARS-CoV-2 and emerging variants
Singh, J., Pandit, P., McArthur, A. G., Banerjee, A., & Mossman, K. L. (2021) · Virology Journal · doi:10.1186/s12985-021-01633-w · Cited by 170
SARS‐CoV‐2 variants and vulnerability at the global level
Chavda, V. P., Patel, A., & Vaghasiya, D. D. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27717 · Cited by 145
Metadata
- Authors
- Romero, P. E., Dávila-Barclay, A., Salvatierra, G., González, L., Cuicapuza, D., Solís, L., Marcos-Carbajal, P., Huancachoque, J., Maturrano, L., & Tsukayama, P.
- Affiliations
- Universidad Peruana Cayetano Heredia (PE)
- Laboratorio de Genómica Microbiana, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Peru
- Laboratorio de Microbiología, Facultad de Medicina Veterinaria, Universidad Nacional Mayor de San Marcos, Lima, Peru
- Corresponding author
- Tsukayama, Pablo
- ORCID
- Venue
- Microbiology Spectrum
- Publisher
- American Society for Microbiology
- Published
- 2021-10-31
- Volume
- 9
- Issue
- 2
- Pages
- e0078921-e0078921
- ISSN
- 2165-0497 (ISSN-L)
- PMC
- PMC8549758
- OpenAlex
- W3210962932
- Cited by
- 85
- References
- 6
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 6 · 2023: 20 · 2022: 35 · 2021: 18
- FWCI
- 6.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (vor)
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Microbiology Spectrum (publishedVersion, cc-by)
- medRxiv (acceptedVersion)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Universidad Peruana Cayetano Heredia Institutional Repository (submittedVersion, cc-by-nc-nd)
- Funders
- Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica (022-2021, 034-2019, 046-2020)
- Universidad Nacional Mayor de San Marcos (A2008007M)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, South America, viral evolution, transmissibility, low- and middle-income countries
- MeSH terms
- COVID-19, SARS-CoV-2, Humans, Mutation, Peru, Genome, Viral, High-Throughput Nucleotide Sequencing
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America. https://app.cochat.ai/papers/10.1128/spectrum.00789-21
- The paper
- Romero, P. E., Dávila-Barclay, A., Salvatierra, G., González, L., Cuicapuza, D., Solís, L., Marcos-Carbajal, P., Huancachoque, J., Maturrano, L., & Tsukayama, P. (2021). The Emergence of Sars-CoV-2 Variant Lambda (C.37) in South America. Microbiology Spectrum. https://doi.org/10.1128/spectrum.00789-21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.